Impediments to clinical research in the United States.
Publication
, Journal Article
Kramer, JM; Smith, PB; Califf, RM
Published in: Clin Pharmacol Ther
March 2012
Clinical trials are essential to the evaluation of promising scientific discoveries, but they are becoming unsustainably burdensome, threatening to deprive patients and health-care providers of new therapies and new evidence to guide the use of existing treatments. Regulations are often blamed for impeding clinical research, but there are other elements of the clinical trials enterprise that also have the potential to add burdens, through either imposed requirements or incentives that do not favor clinical research (Figure 1).
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Clin Pharmacol Ther
DOI
EISSN
1532-6535
Publication Date
March 2012
Volume
91
Issue
3
Start / End Page
535 / 541
Location
United States
Related Subject Headings
- United States
- Pharmacology & Pharmacy
- Humans
- Human Experimentation
- Ethics Committees, Research
- Drug and Narcotic Control
- Clinical Trials as Topic
- Biomedical Research
- Adverse Drug Reaction Reporting Systems
- 3214 Pharmacology and pharmaceutical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kramer, J. M., Smith, P. B., & Califf, R. M. (2012). Impediments to clinical research in the United States. Clin Pharmacol Ther, 91(3), 535–541. https://doi.org/10.1038/clpt.2011.341
Kramer, J. M., P. B. Smith, and R. M. Califf. “Impediments to clinical research in the United States.” Clin Pharmacol Ther 91, no. 3 (March 2012): 535–41. https://doi.org/10.1038/clpt.2011.341.
Kramer JM, Smith PB, Califf RM. Impediments to clinical research in the United States. Clin Pharmacol Ther. 2012 Mar;91(3):535–41.
Kramer, J. M., et al. “Impediments to clinical research in the United States.” Clin Pharmacol Ther, vol. 91, no. 3, Mar. 2012, pp. 535–41. Pubmed, doi:10.1038/clpt.2011.341.
Kramer JM, Smith PB, Califf RM. Impediments to clinical research in the United States. Clin Pharmacol Ther. 2012 Mar;91(3):535–541.
Published In
Clin Pharmacol Ther
DOI
EISSN
1532-6535
Publication Date
March 2012
Volume
91
Issue
3
Start / End Page
535 / 541
Location
United States
Related Subject Headings
- United States
- Pharmacology & Pharmacy
- Humans
- Human Experimentation
- Ethics Committees, Research
- Drug and Narcotic Control
- Clinical Trials as Topic
- Biomedical Research
- Adverse Drug Reaction Reporting Systems
- 3214 Pharmacology and pharmaceutical sciences